All In Biotech

Free tool

FAERS Monitor: Precedex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021038 or its brand name (Precedex, Dexmedetomidine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

2,999

Serious

2,792

93% of reports

Hospitalization

1,116

Death reported

459

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • bradycardia258
  • off label use238
  • hypotension181
  • cardiac arrest172
  • pyrexia116
  • drug ineffective107
  • product use in unapproved indication101
  • pneumonia100
  • product use issue92
  • drug interaction86
  • oxygen saturation decreased86
  • respiratory failure86
  • agitation82
  • product administered to patient of inappropriate age79
  • tachycardia74

Reports by year received

View as table
YearReports
20049
200510
200627
200721
200829
200934
201048
201159
201272
201386
201498
2015104
2016212
2017188
2018192
2019238
2020233
2021207
2022229
2023270
2024246
2025258
2026129

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,160 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product administered to patient of inappropriate ageSignal7992.374.16,952
bradycardiaSignal25834.330.58,285
cardiac arrestSignal17214.612.72,176
oxygen saturation decreasedSignal8610.78.7751
respiratory failureSignal868.36.7544
agitationSignal827.86.3484
hypotensionSignal1816.35.5815
tachycardiaSignal745.84.7293
drug interactionSignal863.83.1176
product use issueSignal923.42.8158
product use in unapproved indicationSignal1012.92.4122
pyrexiaSignal1162.42.090
pneumoniaSignal1002.21.863
off label use2381.91.7106
drug ineffective1070.60.537

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.